HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catalina Barcelo Selected Research

ZY-19489

1/2022Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catalina Barcelo Research Topics

Disease

2Infections
01/2022 - 01/2022
2Malaria
01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

2Antimalarials (Antimalarial Agents)IBA
01/2022 - 01/2022
1ZY-19489IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022